Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Concepts on Pathogenic Mechanisms and Histopathology in Cutaneous Lupus Erythematosus
Tanja Fetter, Christine Braegelmann, Luka de Vos, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 20

Showing 20 citing articles:

Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions
Dennis Niebel, Luka de Vos, Tanja Fetter, et al.
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 4, pp. 521-540
Open Access | Times Cited: 35
Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort study
Henning Olbrich, Khalaf Kridin, Henner Zirpel, et al.
EBioMedicine (2023) Vol. 93, pp. 104639-104639
Open Access | Times Cited: 22
The Spectrum of Cutaneous Manifestations in Lupus Erythematosus: A Comprehensive Review
Aleksandra Fijałkowska, Marcelina Kądziela, Agnieszka Żebrowska
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2419-2419
Open Access | Times Cited: 6
Aberrant inflammasome activation as a driving force of human autoimmune skin disease
Tanja Fetter, Dennis Marinus de Graaf, Isabelle Claus, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Deucravacitinib zeigt eine höhere Wirksamkeit und Sicherheit bei kutanem Lupus erythematodes im Vergleich zu verschiedenen Biologika und niedermolekularen Wirkstoffen: systematische Übersicht und Metaanalyse
Laura Bokor, Katalin Martyin, Máté Krebs, et al.
Kompass Autoimmun (2025), pp. 1-9
Closed Access
Deucravacitinib shows superior efficacy and safety in cutaneous lupus erythematosus compared to various biologics and small molecules – A systematic review and META-analysis
Laura Bokor, Katalin Martyin, Máté Krebs, et al.
Autoimmunity Reviews (2024), pp. 103723-103723
Open Access | Times Cited: 2
Characterization of B cells in lupus erythematosus skin biopsies in the context of different immune cell infiltration patterns
Luka de Vos, Tugce Guel, Dennis Niebel, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 7
Cutaneous lupus erythematosus induced by tislelizumab
Weiquan Chen, Xuan Song, Ying Zhou
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 7, pp. 1003-1004
Closed Access | Times Cited: 1
Nano‐encapsulated anandamide reduces inflammatory cytokines in vitro and lesion severity in a murine model of cutaneous lupus erythematosus
Erika T McCormick, Andrew Draganski, Samantha A. Chalmers, et al.
Experimental Dermatology (2023) Vol. 32, Iss. 12, pp. 2072-2083
Open Access | Times Cited: 3
A lupus erythematosus panniculitis lefolyásának jellegzetességei 17 betegünk retrospektív vizsgálata alapján
Zsófia Király, Anikó Kovács, Márta Medvecz, et al.
Orvosi Hetilap (2023) Vol. 164, Iss. 5, pp. 172-178
Open Access | Times Cited: 2
The differential panorama of clinical features of lupus erythematosus patients with different onset ages: a cross-sectional multicenter study from China
Yangyiyi Yu, Hui Jin, Shihang Zhou, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 9, pp. 2353-2367
Closed Access | Times Cited: 2
Oral lupus erythematosus: Immunohistochemical evaluation of CD1a, CD21, CD123, and langerin expression in dendritic cells
Elisa Raquel Martins da Costa Marques, Ricardo Hsieh, Sílvia Vanessa Lourenço, et al.
Journal of Cutaneous Pathology (2024) Vol. 51, Iss. 5, pp. 368-378
Closed Access
Kutaner Lupus erythematodes ausgelöst durch Tislelizumab
Weiquan Chen, Xuan Song, Ying Zhou
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 7, pp. 1003-1005
Closed Access
Psoriasis and Lupus Erythematosus—Similarities and Differences between Two Autoimmune Diseases
Aleksandra Fijałkowska, Joanna Wojtania, Anna Woźniacka, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4361-4361
Open Access
Innovations in Cutaneous Lupus
Rachel Lin, Peyton V. Warp, Mara Hartoyo, et al.
Dermatologic Clinics (2024) Vol. 43, Iss. 1, pp. 123-136
Closed Access
CUTANEOUS LUPUS ERYTHEMATOSUS – WHAT IS NEW IN 2024?

Reumatizam (2024) Vol. 71, Iss. Supp1
Closed Access
The Intersection of Cutaneous Lupus and Osteonecrosis: Dermatologic Implications for Orthopedic Joint Preservation
Alejandra Sataray-Rodriguez, Jennifer Rasmussen, Klaudia Greer, et al.
Modern Research in Inflammation (2024) Vol. 13, Iss. 04, pp. 43-57
Open Access
Avaliação imuno-histoquímica das células dendríticas no lúpus eritematoso oral
Elisa Raquel Martins da Costa Marques
(2023)
Open Access
Identification of Biomarkers in Affected Hair Follicles from Chronic Discoid Lupus Erythematosus by Weighted Gene Co-Expression Network Analysis
Qitao Chen, Qiuwei Tao, Yuqian Li, et al.
Research Square (Research Square) (2022)
Open Access
Identification of Biomarkers in Affected Hair Follicles from Chronic Discoid LupusErythematosus by Weighted Gene Co-Expression Network Analysis
Qitao Chen, Qiuwei Tao, Yuqian Li, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top